Coherus BioSciences, Inc. (CHRS) financial statements (2020 and earlier)

Company profile

Business Address C/O DENNIS M. LANFEAR
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17872127125158150
Cash and cash equivalents17872127125158150
Restricted cash and investments 00000
Receivables142 1224
Inventory, net of allowances, customer advances and progress billings102    
Inventory102    
Prepaid expense 218323520
Other current assets 00332
Other undisclosed current assets148(1)  2
Total current assets:34384145161197179
Noncurrent Assets
Inventory, Noncurrent454    
Operating lease, right-of-use asset11
Property, plant and equipment671311114
Intangible assets, net (including goodwill)444444
Goodwill111111
Intangible assets, net (excluding goodwill)333333
Restricted cash and investments01111 
Other noncurrent assets000200
Total noncurrent assets:66151717158
TOTAL ASSETS:40999163178212187
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities623325485023
Accounts payable26151520269
Accrued liabilities1779282411
Employee-related liabilities1811   3
Debt2     
Due to related parties     2
Business combination, contingent consideration, liability  3616
Deferred revenue and credits 15023
Other liabilities200000
Other undisclosed current liabilities49 025(2)
Total current liabilities:11533285610652
Noncurrent Liabilities
Long-term debt and lease obligation162777675  
Long-term debt, excluding current maturities152777675  
Operating lease, liability10
Liabilities, other than long-term debt262727284741
Deferred revenue and credits 14540
Due to related parties26262525  
Other liabilities 22220
Business combination, contingent consideration, liability00   1
Other undisclosed noncurrent liabilities    6628
Total noncurrent liabilities:18910510410311369
Total liabilities:304138132159219120
Stockholders' equity
Stockholders' equity attributable to parent105(39)3221(6)67
Common stock000000
Additional paid in capital1,001947808558404254
Accumulated other comprehensive loss(1)(0)(1)(1)(0)(1)
Accumulated deficit(895)(985)(775)(537)(410)(187)
Stockholders' equity attributable to noncontrolling interest  (1)(1)(1)(0)
Total stockholders' equity:105(39)3119(7)67
TOTAL LIABILITIES AND EQUITY:40999163178212187

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues356 21903031
Revenue, net21903031
Cost of revenue
(Cost of Goods and Services Sold)
(0)     
Gross profit:356 21903031
Operating expenses(248)(204)(234)(306)(249)(96)
Other undisclosed operating income0     
Operating income (loss):108(204)(232)(116)(219)(65)
Nonoperating income (expense)353(4)(5)(18)
Other nonoperating income (expense)353(4)(5)(19)
Interest and debt expense(18)(10)(10)(8)(0)(2)
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)     
Income (loss) from continuing operations before equity method investments, income taxes:93(209)(238)(128)(224)(84)
Other undisclosed income from continuing operations before income taxes0     
Income (loss) from continuing operations before income taxes:93(209)(238)(128)(224)(84)
Income tax expense(3)     
Income (loss) before gain (loss) on sale of properties:90(209)(238)(128)(224)(84)
Other undisclosed net loss     (3)
Net income (loss):90(209)(238)(128)(224)(87)
Net income attributable to noncontrolling interest 00010
Net income (loss) available to common stockholders, diluted:90(209)(238)(127)(223)(87)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):90(209)(238)(128)(224)(87)
Other undisclosed comprehensive income (loss)(0)0(0)(0)0(1)
Comprehensive income (loss):90(209)(238)(128)(224)(88)
Comprehensive income, net of tax, attributable to noncontrolling interest 00010
Comprehensive income (loss), net of tax, attributable to parent:90(209)(238)(128)(223)(88)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: